✨
AI Summary
- Biotech sponsors must make earlier, smarter global trial decisions.
- Adapting to evolving FDA initiatives and accelerated pathways is crucial.
- Experts advise on navigating global regulatory expectations for drug development.
Guests on This Episode
RH
Renita Hite
2 podcast appearances
SS
Scott Schliebner
2 podcast appearances